Medifast, Inc.
MEDNYSEConsumer Cyclical● Active
$12.10
$-0.17(-1.39%)
Market Cap$134541110
P/E Ratio—
52W High$15.46
52W Low$9.22
Medifast, Inc. (MED) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MED · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.39B | $0.60B | $1.07B | $1.60B | $1.53B |
| Cost of Revenue | $0.11B | $0.16B | $0.30B | $0.46B | $0.40B |
| Gross Profit | $0.28B | $0.44B | $0.78B | $1.14B | $1.13B |
| Gross Margin %(computed) | 71.33% | 73.80% | 72.37% | 71.34% | 73.89% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.29B | $0.44B | $0.65B | $0.96B | $0.91B |
| Operating Income | ($0.01B) | $0.00B | $0.13B | $0.18B | $0.22B |
| Operating Margin %(computed) | -3.68% | 0.48% | 11.79% | 11.56% | 14.17% |
| Interest Income | $0.01B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.01B) | $0.00B | $0.13B | $0.18B | $0.22B |
| Income Tax Expense | $0.01B | $0.00B | $0.03B | $0.04B | $0.05B |
| Net Income | ($0.02B) | $0.00B | $0.10B | $0.14B | $0.16B |
| Net Margin %(computed) | -4.84% | 0.35% | 9.27% | 8.98% | 10.75% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.70 | $0.19 | $9.10 | $12.82 | $14.01 |
| Wtd Avg Shares | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B |
| EBITDA | ($0.00B) | $0.02B | $0.14B | $0.20B | $0.22B |
| EBITDA Margin %(computed) | -0.96% | 2.59% | 13.01% | 12.24% | 14.62% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Medifast, Inc. data
About Medifast, Inc. (MED) Income Statement
Medifast, Inc. (MED) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, MED reported revenue of $0.39B, gross profit of $0.28B (gross margin 71.33%), and net income of ($0.02B) — a net profit margin of -4.84%.
Frequently asked questions
MED · 4 questionsMedifast, Inc. (MED) reported revenue of $0.39B for 2025, down 36.0% year-over-year.
MED revenueMED salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08